170 related articles for article (PubMed ID: 33240930)
21. Pan-cancer analysis reveals NUP37 as a prognostic biomarker correlated with the immunosuppressive microenvironment in glioma.
He Y; Li J; Shen L; Zhou H; Fei W; Zhang G; Li Z; Wang F; Wen Y
Aging (Albany NY); 2022 Jan; 14(2):1033-1047. PubMed ID: 35093934
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and prognostic value of secreted protein acidic and rich in cysteine in the diffuse large B-cell lymphoma.
Pan PJ; Liu JX
World J Clin Cases; 2021 Aug; 9(22):6287-6299. PubMed ID: 34434995
[TBL] [Abstract][Full Text] [Related]
23. Multi-Omics Analysis Showed the Clinical Value of Gene Signatures of C1QC
Li X; Zhang Q; Chen G; Luo D
Front Immunol; 2021; 12():694801. PubMed ID: 34295336
[TBL] [Abstract][Full Text] [Related]
24. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
[TBL] [Abstract][Full Text] [Related]
25. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
[TBL] [Abstract][Full Text] [Related]
26. FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer.
Zhong A; Chen T; Xing Y; Pan X; Shi M
Front Immunol; 2021; 12():758648. PubMed ID: 34745134
[TBL] [Abstract][Full Text] [Related]
27. Prognostic and immunological role of Fam20C in pan-cancer.
Liu X; Zhan Y; Xu W; Liu X; Geng Y; Liu L; Da J; Wang J; Zhang X; Jin H; Liu Z; Guo S; Zhang B; Li Y
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33306121
[TBL] [Abstract][Full Text] [Related]
28. Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma.
Cai D; Zhao Z; Hu J; Dai X; Zhong G; Gong J; Qi F
Front Surg; 2022; 9():836080. PubMed ID: 35392063
[TBL] [Abstract][Full Text] [Related]
29. Evaluating the Prognostic Value of microRNA-203 in Solid Tumors Based on a Meta-Analysis and the Cancer Genome Atlas (TCGA) Datasets.
Shao Y; Gu W; Ning Z; Song X; Pei H; Jiang J
Cell Physiol Biochem; 2017; 41(4):1468-1480. PubMed ID: 28351024
[TBL] [Abstract][Full Text] [Related]
30. OGDHL closely associates with tumor microenvironment and can serve as a prognostic biomarker for papillary thyroid cancer.
Mao M; Huang RZ; Zheng J; Liang HQ; Huang WH; Liu J; Li JH
Cancer Med; 2021 Jan; 10(2):728-736. PubMed ID: 33405394
[TBL] [Abstract][Full Text] [Related]
31. Immunological Role and Prognostic Value of APBB1IP in Pan-Cancer Analysis.
Ge Q; Li G; Chen J; Song J; Cai G; He Y; Zhang X; Liang H; Ding Z; Zhang B
J Cancer; 2021; 12(2):595-610. PubMed ID: 33391455
[No Abstract] [Full Text] [Related]
32. Distinct Osteomimetic Response of Androgen-Dependent and Independent Human Prostate Cancer Cells to Mechanical Action of Fluid Flow: Prometastatic Implications.
González Á; García de Durango C; Alonso V; Bravo B; Rodríguez de Gortázar A; Wells A; Forteza J; Vidal-Vanaclocha F
Prostate; 2017 Feb; 77(3):321-333. PubMed ID: 27813116
[TBL] [Abstract][Full Text] [Related]
33. P4HA1, a Prognostic Biomarker that Correlates With Immune Infiltrates in Lung Adenocarcinoma and Pan-Cancer.
Zhao Q; Liu J
Front Cell Dev Biol; 2021; 9():754580. PubMed ID: 34966739
[No Abstract] [Full Text] [Related]
34. Leptin Receptor Overlapping Transcript (LEPROT) Is Associated with the Tumor Microenvironment and a Prognostic Predictor in Pan-Cancer.
Li B; He Y; Li P; Chen X
Front Genet; 2021; 12():749435. PubMed ID: 34804118
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
Li C; Liu T; Liu Y; Zhang J; Zuo D
J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
[TBL] [Abstract][Full Text] [Related]
36. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
[TBL] [Abstract][Full Text] [Related]
37. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
38. Pan-Cancer Analysis Reveals the Multidimensional Expression and Prognostic and Immunologic Roles of
Zhang S; Xiong H; Yang J; Yuan X
Front Mol Biosci; 2021; 8():792154. PubMed ID: 35155565
[TBL] [Abstract][Full Text] [Related]
39. LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers.
Xiao J; Liu Y; Yi J; Liu X
Front Mol Biosci; 2021; 8():646786. PubMed ID: 33996902
[TBL] [Abstract][Full Text] [Related]
40. A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor.
Mo Z; Li P; Cao Z; Zhang S
Front Immunol; 2021; 12():564948. PubMed ID: 34290693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
